Avenacy Announces Launch of Desmopressin Acetate for Injection in the U.S. Market [Yahoo! Finance]
IQVIA Holdings, Inc. (IQV)
Last iqvia holdings, inc. earnings: 4/28 07:00 am
Check Earnings Report
US:NYSE Investor Relations:
ir.iqvia.com
Company Research
Source: Yahoo! Finance
SCHAUMBURG, Ill., April 15, 2024 BUSINESS WIRE )--Avenacy, a specialty pharmaceutical company focused on supplying critical injectable medications, today announced it has launched Desmopressin Acetate for Injection in the United States as a therapeutic equivalent generic for DDAVP ® for Injection (Desmopressin Acetate) approved by the U.S. Food and Drug Administration. Desmopressin Acetate for Injection is multi-indicated for patients with central diabetes insipidus, hemophilia A, and von Willebrand's disease (Type I). Avenacy's Desmopressin Acetate for Injection is available in two presentations: 4 mcg per 1 mL single-dose vials, and 40 mcg per 10 mL multiple-dose vials. In line with Avenacy's mission to champion patient safety and streamline patient care, Desmopressin Acetate for Injection will feature the Company's highly differentiated packaging and labeling to support accurate medication selection. Avenacy will begin shipping Desmopressin Acetate for Injection to wholesale p
Show less
Read more
Impact Snapshot
Event Time:
IQV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IQV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IQV alerts
High impacting IQVIA Holdings, Inc. news events
Weekly update
A roundup of the hottest topics
IQV
News
- IQVIA (IQV) to Report Q1 Earnings: What's in the Offing? [Yahoo! Finance]Yahoo! Finance
- Avenacy Announces Launch of Eptifibatide for Injection in the U.S. Market [Yahoo! Finance]Yahoo! Finance
- How AI-Driven Diagnostics Can Save Lives When Humans Can't [Forbes]Forbes
- Contract Research Organization Services Market Projected to Reach $184.21 billion by 2030 - Exclusive Report by 360iResearch [Yahoo! Finance]Yahoo! Finance
- Cegedim achieves solid growth in first quarter 2024 [Yahoo! Finance]Yahoo! Finance
IQV
Earnings
- 2/14/24 - Beat
IQV
Sec Filings
- 4/17/24 - Form 8-K
- 3/4/24 - Form 4
- 3/4/24 - Form 4
- IQV's page on the SEC website